Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer’s Disease

31 Jan 2025

Abstract excerpt

Alzheimer’s disease (AD) is the most common form of dementia and is characterized by memory impairment that significantly interferes with daily life. Therapeutic options for AD that substantively modify disease progression remain a critical unmet need. In this regard, the gut microbiota is crucial in maintaining human health by regulating metabolism and immune responses, and increasing evidence suggests that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Gut microbiota and health
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39940416
DOI: 10.3390/nu17030558

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer’s DiseasePMID 39940416Read ↗

Administration of Bifidobacterium breve Improves the Brain Function of Aβ1-42-Treated Mice via the Modulation of the Gut MicrobiomeSemantic proximity Read ↗

The Microbiome and Alzheimer’s Disease: Potential and Limitations of Prebiotic, Synbiotic, and Probiotic FormulationsSemantic proximity Read ↗

Bifidobacterium breve intervention combined with environmental enrichment alleviates cognitive impairment by regulating the gut microbiota and microbial metabolites in Alzheimer’s disease miceSemantic proximity Read ↗

Using Synbiotics as a Therapy to Protect Mental Health in Alzheimer's DiseaseSemantic proximity Read ↗

Association Between the Gut Microbiota and Alzheimer’s Disease: An Update on Signaling Pathways and Translational TherapeuticsSemantic proximity Read ↗

The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to TreatmentSemantic proximity Read ↗

Bifidobacterium Lactis Probio-M8 regulates gut microbiota to alleviate Alzheimer’s disease in the APP/PS1 mouse modelSemantic proximity Read ↗

The Microbiota–Gut–Brain Axis in Alzheimer’s Disease: A Review of Taxonomic Alterations and Potential Avenues for InterventionsSemantic proximity Read ↗

Next Generation Probiotics Relevance to Neurodegenerative Diseases: Novel Therapeutic PerspectiveSemantic proximity Read ↗

Eucommiae cortex polysaccharides ameliorates learning and memory deficits in Alzheimer's disease mice by modulating gut microbiota and glutamate metabolismSemantic proximity Read ↗

Probiotics for Neurodegenerative Diseases: A Systemic ReviewSemantic proximity Read ↗

Effect of Clostridium butyricum against Microglia‐Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites ButyrateSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.